title: [Observation of portal systemic circulation after sclerotherapy and/or splenic embolization studied by Tl-201 per-rectal administration].
authors.forename: N
authors.initials: N
authors.lastname: Tonami
authors.forename: K
authors.initials: K
authors.lastname: Nakajima
authors.forename: S
authors.initials: S
authors.lastname: Kawabata
authors.forename: Y
authors.initials: Y
authors.lastname: Shire
authors.forename: T
authors.initials: T
authors.lastname: Michigishi
authors.forename: N
authors.initials: N
authors.lastname: Watanabe
authors.forename: M
authors.initials: M
authors.lastname: Seto
authors.forename: K
authors.initials: K
authors.lastname: Yokoyama
authors.forename: N
authors.initials: N
authors.lastname: Shuke
authors.forename: S
authors.initials: S
authors.lastname: Tsuji
mesh_terms: D000285:Administration, Rectal; D000368:Aged; D004621:Embolization, Therapeutic; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005260:Female; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging*; D008102:Liver Circulation; D008297:Male; D008875:Middle Aged; D011169:Portal Vein / Q000503:physiopathology; D011877:Radionuclide Imaging; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D013154:Spleen; D013793:Thallium / Q000008:administration & dosage
chemical_list: D012597:Sclerosing Solutions; C027549:thallium chloride; D013793:Thallium